RR 222
Commercial- Indications
- Aging, Inflammation
Company intelligence / Profile preview
Moonshot Biotech
Singapore, Singaporemoonshotbiotech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Moonshot Biotech has developed Lipid Bond technology for hair repair that creates Small Molecule Real Lipids mimicking hair's natural lipids to reverse damage. They also have RR 222 with Lipid-Based Delivery System technology for skin anti-aging applications[1][2][4].
- Therapeutic areas
- Dermatology
- Modalities
- Small molecule bioactive ingredients
- Industry
- Non-Drug Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Moonshot Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Moonshot Biotech.